Affiliated Hospital of Guilin Medical University

Guilin, Guangxi 541001

0 studies enrolling now · 5 studies all time

What they study most

Complicated Intra-abdominal Infection, Extensive-Stage Small-Cell Lung Cancer, Gastric, or Gastroesophageal Junction Adenocarcinoma, Hosptial Acquired Pneumonia, Nasopharyngeal Carcinoma, Small-Cell Lung Cancer, Solid Tumors, Ventilator Associated Pneumonia

Studies at this site

• Study Comparing Tarlatamab and Durvalumab Versus Durvalumab Alone in First-Line Extensive-Stage Small-Cell Lung Cancer (ES-SCLC) Following Platinum, Etoposide and Durvalumab — Running, not enrolling
• A Study of Penpulimab (AK105) in the First-line Treatment of Recurrent or Metastatic Nasopharyngeal Carcinoma — Running, not enrolling
• Tislelizumab in Combination With Chemotherapy as First-Line Treatment in Adults With Inoperable, Locally Advanced or Metastatic Gastric, or Gastroesophageal Junction Carcinoma — Completed
• Study to Assess the Long-term Safety of Lenvatinib Monotherapy, a Lenvatinib Combination Regimen, or a Comparator Treatment Arm to Cancer Participants in Eisai Sponsored Lenvatinib Trials — Completed
• A Study to Determine the Efficacy, Safety and Tolerability of Aztreonam-Avibactam (ATM-AVI) ± Metronidazole (MTZ) Versus Meropenem (MER) ± Colistin (COL) for the Treatment of Serious Infections Due to Gram Negative Bacteria. — Completed